Skip to main content
Celemics, Inc. logo

Celemics, Inc. — Investor Relations & Filings

Ticker · 331920 ISIN · KR7331920009 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 331920

About Celemics, Inc.

https://www.celemics.com/

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings
2026-04-30 Korean
증권발행결과(자율공시)
Regulatory Filings
2026-04-30 Korean
[기재정정]증권발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a regulatory disclosure of the results of a securities issuance (private placement of convertible bonds), including correction of the planned issue amount and final amounts raised. It is not an earnings release, AGM material, or call transcript but a direct update on the company’s financing activity. Therefore it falls under Capital/Financing Update.
2026-04-29 Korean
[기재정정]증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a voluntary disclosure detailing the issuance results of securities (convertible bonds), including correction of issuance amounts, issuance method, dates, and related notices. This clearly pertains to a share issue/capital change (issuance of convertible bonds alters the company’s capital structure). Therefore, it should be classified under Share Issue/Capital Change.
2026-04-29 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a detailed regulatory disclosure (“주요사항보고서”) concerning the decision to issue convertible bonds, including correction (“정정”) details: issuance amounts, purpose of funding, conversion terms, and related financing schedules. This is not an earnings release or annual report, but a specific corporate financing update. Therefore it best fits the Capital/Financing Update category.
2026-04-29 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement in Korean of the result of a securities issuance (private placement convertible bonds), with details on issuance type, amount, dates, and listing status. This corresponds to a share issue/capital change announcement rather than an earnings report or other category.
2026-04-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.